CD33 and hematopoietic and lymphoid cell neoplasm: Here we studied IGK expression in sorted CD33+CD19−CD138− myeloblasts from 18 AML patients, and monocytes and neutrophils from 12 patients with non-hematopoietic neoplasms and 8 healthy individuals.